Discovery Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2024-07-04 ms9000000384385105 来自上海

不错

84 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2021-04-13 14826b34m49(暂无昵称)

审稿时间挺长的，版面费挺贵的。

102 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2023-12-21 ms8000000748330837 来自广东省

请问是所有作者都需要同意OA和APC才会送审吗

74 0

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2023-07-08 ms5000001974101260 来自广东省

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤
经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催

81 0

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2016-09-30 公子徵羽

投了2个多月一直pending review 什么个情况~~

198 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2022-05-14 ms2000001259468299

审稿速度:1.0 | 投稿命中率:75.0
经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。

82 0

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2019-06-14 12448c09m19(暂无昵称)

请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表:
我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！

大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！

151 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2021-12-29 Mia

如何计算相关性？

86 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

什么是协同作用？什么是相加作用？两者有什么区别？

86 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213243, encodeId=dbc5221324318, content=不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42a59196717, createdName=ms9000000384385105, createdTime=Thu Jul 04 17:27:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=956509, encodeId=d423956509d6, content=审稿时间挺长的，版面费挺贵的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74d85272483, createdName=14826b34m49(暂无昵称), createdTime=Tue Apr 13 11:27:03 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2176213, encodeId=5e4121e621324, content=请问是所有作者都需要同意OA和APC才会送审吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac08627111, createdName=ms8000000748330837, createdTime=Thu Dec 21 00:42:32 CST 2023, time=2023-12-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147039, encodeId=e88a214e0390b, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：三月投的，四月底外审结束，然后从等待编辑决定，又变成Editor appointed，六月又变成等待编辑决定，然后从等待编辑决定，发邮件回复感觉看心情，一两个周回复一次，只说会催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62ab6548381, createdName=ms5000001974101260, createdTime=Sat Jul 08 23:17:18 CST 2023, time=2023-07-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=527766, encodeId=678552e7667d, content=投了2个多月一直pending review 什么个情况~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d1c1675179, createdName=公子徵羽, createdTime=Fri Sep 30 01:43:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219547, encodeId=9bad121954e0c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问这个杂志自己发表的文章怎么获得pdf版本，给编辑发邮件也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f2c6493644, createdName=ms2000001259468299, createdTime=Sat May 14 11:24:08 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572273, encodeId=bb835e22739c, content=请问你的是on line了么，我的有半个月编辑就发给我说小修下录用，要划走一千多美金的版面费，总感觉投错杂志了，正规么大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, beContent=大黑 2019-03-25 00:00:00 发表: 我最近也在discovery medicine上投了一篇文章，编辑私发邮件告诉我文章小修一下，发给他，就可以录用了，现在钱已经被划走了，但是还没有给录用通知，想了解一下你们的文章当时是什么情况呢，如果你们看见的话，希望能回复我一下，真的真的感谢你们，因为这篇文章对我很重要！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3a2475605, createdName=12448c09m19(暂无昵称), createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104839, encodeId=97a211048398a, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104840, encodeId=83de1104840be, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015386, encodeId=84b4101538634, content=很垃圾不要投，从头到尾有种上当受骗的感觉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=539c1670053, createdName=xiaoxiao2016, createdTime=Tue Sep 07 15:45:44 CST 2021, time=2021-09-07, status=1, ipAttribution=)]

2021-09-07 xiaoxiao2016

很垃圾不要投，从头到尾有种上当受骗的感觉

98 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务